Pfizer Inc (NYSE:PFE)
$ 28.27 0.5 (1.8%) Market Cap: 160.08 Bil Enterprise Value: 215.40 Bil PE Ratio: 0 PB Ratio: 1.79 GF Score: 78/100

Q3 2021 Pfizer Inc Earnings Call Transcript

Nov 02, 2021 / 02:00PM GMT
Release Date Price: $45.45 (+4.15%)
Operator

Good day, everyone, and welcome to Pfizer's Third Quarter 2021 Earnings Conference Call. Today's call is being recorded.

At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thank you, Sylvia. Good morning. Welcome to Pfizer's Third Quarter Earnings Call. I'm joined today by Dr. Albert Bourla, our Chairman and CEO; Frank D'Amelio, our CFO; Mikael Dolsten, President of Worldwide Research and Development and Medical; Angela Hwang, Group President, Pfizer Biopharmaceuticals Group; Aamir Malik, our Chief Business and Innovation Officer; and Doug Lankler, General Counsel.

We expect this call to last 90 minutes. Materials for this call and other earnings-related materials are on the Investor Relations section of pfizer.com. Please see our forward-looking statements disclosure on Slide 3, which is shown right now. And additional information regarding these statements and our non-GAAP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot